» Authors » Laura Stronati

Laura Stronati

Explore the profile of Laura Stronati including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 71
Citations 2810
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Laudadio I, Leter B, Palone F, Cucchiara S, Carissimi C, Scafa N, et al.
Immun Inflamm Dis . 2024 Oct; 12(10):e70036. PMID: 39377749
Objective And Rationale: Inflammatory bowel disease, including Crohn's disease and ulcerative colitis, manifests with chronic intestinal inflammation and frequent sequential fibrosis. Current pharmacological therapies may show harmful side effects and...
2.
Toto F, Marangelo C, Scanu M, De Angelis P, Isoldi S, Abreu M, et al.
Int J Mol Sci . 2024 Sep; 25(17). PMID: 39273567
Recent evidence indicates that the gut microbiota (GM) has a significant impact on the inflammatory bowel disease (IBD) progression. Our aim was to investigate the GM profiles, the Microbial Dysbiosis...
3.
Vitali R, Novelli F, Palone F, Cucchiara S, Stronati L, Pioli C
Immunol Lett . 2024 Sep; 270:106912. PMID: 39237041
Inflammatory bowel diseases (IBD) are chronic relapsing disorders with increasing prevalence. Knowledge gaps still limit the possibility to develop more specific and effective therapies. Using a dextran sodium sulfate colitis...
4.
Laudadio I, Carissimi C, Scafa N, Bastianelli A, Fulci V, Renzini A, et al.
Inflamm Res . 2024 Jun; 73(8):1359-1370. PMID: 38842554
Background And Aims: Intestinal fibrosis is a common complication of Inflammatory Bowel Disease (IBD), namely Crohn's disease (CD) and ulcerative colitis (UC), but the precise mechanism by which it occurs...
5.
Vitali R, Mancuso A, Palone F, Pioli C, Cesi V, Negroni A, et al.
Int J Mol Sci . 2023 Apr; 24(8). PMID: 37108260
Extracellular High-mobility group box 1 (HMGB1) contributes to the pathogenesis of inflammatory disorders, including inflammatory bowel diseases (IBD). Poly (ADP-ribose) polymerase 1 (PARP1) has been recently reported to promote HMGB1...
6.
Fiaschini N, Mancuso M, Tanori M, Colantoni E, Vitali R, Diretto G, et al.
Int J Mol Sci . 2022 Nov; 23(22). PMID: 36430732
A tight relationship between gut-liver diseases and brain functions has recently emerged. Bile acid (BA) receptors, bacterial-derived molecules and the blood-brain barrier (BBB) play key roles in this association. This...
7.
Laudadio I, Bastianelli A, Fulci V, Carissimi C, Colantoni E, Palone F, et al.
Int J Mol Sci . 2022 Sep; 23(18). PMID: 36142169
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the gastrointestinal tract. Chronic inflammation is the main factor leading to intestinal fibrosis, resulting in recurrent stenosis, especially...
8.
Vitali R, Palone F, Armuzzi A, Fulci V, Negroni A, Carissimi C, et al.
J Crohns Colitis . 2022 Aug; 17(1):92-102. PMID: 36040453
Background: Faecal biomarkers have emerged as important tools in managing of inflammatory bowel disease [IBD], which includes Crohn's disease [CD] and ulcerative colitis [UC]. Aim: To identify new biomarkers of...
9.
Colantoni E, Palone F, Cesi V, Leter B, Sugoni G, Laudadio I, et al.
Sci Rep . 2022 Feb; 12(1):3127. PMID: 35210548
Microalgae are natural sources of valuable bioactive compounds, such as polyunsaturated fatty acids (PUFAs), that show antioxidant, anti-inflammatory, anticancer and antimicrobial activities. The marine microalga Isochrysis galbana (I. galbana) is...
10.
Fiaschini N, Negroni A, Palone F, Vitali R, Colantoni E, Laudadio I, et al.
Dig Liver Dis . 2021 Dec; 54(8):1084-1093. PMID: 34903499
Background: The incidence of non-alcoholic fatty liver disease (NAFLD) and its more severe and progressive form, non-alcoholic steatohepatitis (NASH) is increasing worldwide. Gut inflammation seems to concur to the pathogenesis...